Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02069912 · ClinicalTrials.gov registry record · NA
Multifaceted Depression and Cardiovascular Program
A NA study of Depression and Depressive Disorder, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT02069912: Completed NA study of Depression and Depressive Disorder, sponsored by University of Southern California.
NCT02069912 is a NA study of Depression and Depressive Disorder that has completed, run by University of Southern California. The registered enrollment target is 108 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02069912, a NA study of Depression and Depressive Disorder, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Implement an evidence-based structured care approach that includes screening; acute treatment and relapse prevention follow-up tailored for public sector clinics and low-income and minority patients. 2. Adapt an evidence-based collaborative care model for primary care, implement the adapted model, evaluate and further refine the model based on the pilot experience, and produce and disseminate a detailed manual for use in public sector clinics. 3. Evaluate Multifaceted Depression and Cardiovascular Program (MDCP) in an open trial to determine: its acceptance by patients, medical providers, and organizational decision-makers; patient depression treatment adherence; its direct cost; and the size and variability of change from baseline in the primary outcome measures: depressive symptoms, functional status, quality of life, health service use, and cardiac status at 6 and 12 month follow-up.
Primary Outcome
Achieve minimum a 50% reduction in depressive symptoms from baseline at 6- and 12-month follow-up
Conditions Studied
Interventions
- BEHAVIORAL Collaborative depression care management
Study Locations (1)
California
- University of Southern California School of Social Work - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT02069912 record still lists
NCT02069912 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (86% lower).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Collaborative depression care management is the first listed.
NCT02069912 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02069912 about?
NCT02069912 is a clinical study titled "Multifaceted Depression and Cardiovascular Program". 1. Implement an evidence-based structured care approach that includes screening; acute treatment and relapse prevention follow-up tailored for public sector clinics and low-income and minority patients. 2. Adapt an evidence-based collaborative care model for primary care, implement the adapted model...
What is the current status of trial NCT02069912?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2006-11. Estimated completion is 2009-02.
What conditions does trial NCT02069912 study?
This clinical trial studies the following conditions: Depression, Depressive Disorder, Mood Disorders, Behavioral Symptoms.
What interventions are being tested in trial NCT02069912?
The interventions under investigation include: Collaborative depression care management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02069912?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02069912 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02069912's enrollment target sits among peer trials
108 311th of 679 higher than 366 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia